Epinephrine Injector

The Defense Logistics Agency is preparing to issue a competitive solicitation for a national requirements contract to procure Epinephrine 0.3 MG/0.3 ML Injection Auto-Injectors packaged in 2-count bottles, intended for use by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be structured as a firm-fixed-price, requirements-type agreement with a one-year base period and four optional one-year extensions, designed to serve as the primary national supply source under FAR 52.216-21. The acquisition will be unrestricted and fully open to all qualified vendors, treated as a commercial item under FAR Part 12, with no set-aside provisions. Annual usage estimates will be specified in the solicitation’s Schedule of Supplies, and the contract will facilitate procurement through the DLA and VA prime vendor programs. The solicitation number is SPE2D2-26-R-0009, with a NAICS code of 325412 for pharmaceutical manufacturing, and it is being managed by DLA Troop Support out of Philadelphia, Pennsylvania. The pre-solicitation notice was posted on April 29, 2026, with the anticipated solicitation release set for August 2026, though DLA retains the authority to adjust the timing. Interested parties can access the full solicitation details through the DIBBS and SAM.gov websites and are encouraged to set up automated alerts for updates. Primary points of contact are Jeremy Brown and Jason Wray, available for inquiries via email and phone, with all proposals expected to be submitted in response to the formal solicitation once published.